期刊
CURRENT CANCER DRUG TARGETS
卷 14, 期 2, 页码 156-166出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1568009613666131126115444
关键词
Colon cancer cells; curcumin; curcumin derivative; ER stress; mitochondrial dysfunction; ROS
类别
资金
- National Natural Science Foundation of China, Key Program [30930105]
- National 12-5 Support Plan Project of the Ministry of Science and Technology of China [2012BAH30F03]
- National Natural Science Foundation of China [31070740, 21172101]
- Xi'an Jiaotong University
Curcumin, a polyphenol isolated from the plant Curcuma longa, displays chemotherapeutic and chemo-preventive effects in diverse cancers, including colorectal cancer. A mono-carbonyl analogue B63 was synthesized through several chemical modifications of the basic structure of curcumin to increase its biological activity and bioavailability. In vitro assays showed potent anti-proliferative effects of B63 on colon cancer cells (about 2 fold more effective than curcumin based on IC50). B63 treatment also induced significant necrosis, apoptosis, and S phase cell cycle arrest in SW620 colon cancer cells. The pro-apoptotic proteins Bad and Bim were up-regulated, and cytochrome c release from the mitochondria into the cytosol was enhanced, resulting in pro-caspase-3 and PARP-1 cleavage. Furthermore, the anticancer activity of B63 was dependent on intracellular ROS from damaged mitochondrial function and induced endoplasmic reticulum (ER) stress. In vivo, 50 mg/kg of B63 inhibit tumor growth similarly to 100 mg/kg curcumin in a mouse xenograft model using SW620 cells. These results suggest that the curcumin derivative B63 has a greater anticancer capacity than the parent curcumin in colon cancer cells and that the necrotic and apoptotic effects of B63 are mediated by ROS resulting from ER stress and mitochondrial dysfunction.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据